Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Misinformation about ivermectin as a cancer treatment is on the rise, with social media and public figures fueling false ...

Biocon's share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company's seventh USFDA ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug.

An episode of the "Joe Rogan Experience" podcast, seen by more than 10 million, appears to have reignited interest in the ...

Tempest Therapeutics is eyeing a strategic partner to continue amezalpat’s development amid ‘unavailable capital markets'.

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...